Medindia

X

Western States Biopharmaceuticals and University of Colorado Announce Exclusive Licensing Agreement for TCISM™ Targets to Treat Autoimmune Diseases

Thursday, July 8, 2010 General News J E 4
Advertisement
Licensed Technology is a Novel Approach to Treating Inflammatory Disease while Preserving Immune Protection

For Western States Biopharmaceuticals:

Felicia Vonella, LAS Communications

(917) 826-3427

felicia@lascommunications.com

For University of Colorado:

Lindsay Polak

Technology Transfer Office

(303) 735-5518

lindsay.polak@cu.edu

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Lehigh Valley Respiratory Care Selects Authentidat...
S
Risking It All for Love: New Fiction Takes Readers...